Neuroprotective potential of phytochemicals

Pharmacognosy Reviews

Volumn 6, Issue 12, 2012, Pages 81-90

  Kumar, G Phani ^a   Khanum, Farhath ^a  

^a DEFENCE FOOD RESEARCH LABORATORY   (India)

Author keywords

Antioxidants; medicinal plants; neuroprotective herbs; nootropics; phytochemicals

Indexed keywords

ACORUS CALAMUS EXTRACT; ALKALOID DERIVATIVE; ALLICIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CENTELLA ASIATICA EXTRACT; CURCUMIN; FLAVONOID; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERICIN; HYPERICUM EXTRACT; LYCOPENE; NOOTROPIC AGENT; PHENOL DERIVATIVE; PLANT MEDICINAL PRODUCT; POLYUNSATURATED FATTY ACID; PSEUDOHYPERICIN; RESVERATROL; SULFORAPHANE; TERPENOID;

ACORUS CALAMUS; ALLIUM; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; AYURVEDA; BACOPA MONNIERI; CENTELLA ASIATICA; CHINESE MEDICINE; CORYDALIS TERNATA; DRUG STRUCTURE; EPILEPSY; EVOLVULUS; GARLIC; GINKGO BILOBA; GINSENG; GLYCYRRHIZA GLABRA; HUPERZIA SERRATA; HYPERICUM; IN VITRO STUDY; IN VIVO STUDY; MAGNOLIA OFFICINALIS; NERVE REGENERATION; NEUROPROTECTION; NEUROPSYCHIATRY; OXIDATIVE STRESS; PIPER METHYSTICUM; PLANT LEAF; REVIEW; RHYNCHOPHYLLA; TERMINALIA CHEBULA; UNCARIA; VALERIANA OFFICINALIS; WITHANIA SOMNIFERA; ZINGIBER OFFI CINALE; ZIZIPHUS SPINOSA;

EID: 84866668465     PISSN: 09737847     EISSN: 09762787     Source Type: Journal    
DOI: 10.4103/0973-7847.99898     Document Type: Review

References (66)

1. Halliwell B. Reactive oxygen species and central nervous systems. J Neurochem 1992;59:1609-23.
2. Kolominsky Rabas PL, Sarti C, Heuschmann PU, Graf C, Siemonsen S, Neundoerfer B, et al. A prospective communitybased study of stroke in Germany. The Erlangen Stroke Project (ESPro): Incidence and case fatality at 1, 3, and 12 months. Stroke 1998;29;2501-6.
3. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger Gateau P, Dartigues JF. Intake of fl avonoids and risk of dementia. Eur J Epidemiol 2000;6:357-63.
4. Kumar V. Potential medicinal plants for CNS disorders: An overview. Phytother Res 2006;20:1023-35.
5. Selvam AB. Inventory of Vegetable Crude Drug samples housed in Botanical Survey of India, Howrah. Pharmacognosy Rev 2008;2:61-94.
6. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev 2010;4:118-26.
7. Pueyo IU, Calvo MI. Phytochemical Study and Evaluation of Antioxidant, Neuroprotective and Acetylcholinesterase Inhibitor Activities of Galeopsis ladanum L. extracts. Pharmacognosy Mag 2009;5:287-90.
8. Houghton PJ, Raman A. Laboratory handbook for fractionation of natural extracts. London: Chapman and Hall; 1998. p. 199.
9. Capasso R, Izzo AA, Pinto L, Bifulco T, Vitobello C, Mascolo N. Phytotherapy and quality of herbal medicines. Fitoterapia 2000;71:S58-65.
10. Plotkin MJ. Ethnomedicine: Past, present and future. In: Natural resources and human health: Plants of medicinal and nutritional value. Proceedings. Amsterdam: Elsevier; 1992. p. 79-86.
11. Harvey AL. Medicines from nature: Are natural products still relevant to drug discovery? Trends Pharmacol Sci 1999;20:196-8.
12. Gong X, Sucher NJ. Stroke therapy in traditional Chinese medicine (TCM): Prospects for drug discovery and development. Trends Pharmacol Sci 1999;20:191-6.
13. Chandrasekaran K, Mehrabian Z, Spinnewyan B, Drieu K, Kiskum G. Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia. Brain Res 2001;922:282-92.
14. Nocerino E, Amato M, Izzo AA. The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia 2000;71:S1-5.
15. Anand T, Naika M, Swamy MS, Khanum F. Antioxidant and DNA damage preventive properties of Bacopa monniera (L) Wettst. Free Rad Antioxidants 2011;1:89-95.
16. Singh HK, Dhawan BN. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Indian J Pharmacol 1997;29:S359-65.
17. Russo A, Borrelli F. Bacopa Monniera, A reputed nootropic plant: An overview. Phytomedicine 2005;12:305-17.
18. Nalini K, Aroor A, Karanth K, Rao A. Centella asiatica fresh leaf aqueous extract on learning and memory and biogenic amine turnover in albino rats. Fitoterapia 1992;63:232-7.
19. Anand T, Naika M, Kumar PG, Khanum F. Antioxidant And DNA Damage Preventive Properties Of Centella asiatica (L). Urb., Pharmacognosy Mag 2011:2:53-8.
20. Weiss RF, Fintelmann V. Herbal Medicine. Stuttgart: Thieme; 2000 3-20.
21. Viana M, Barbas C, Banet B, Bonet MV, Castro M, Fraile MU, et al. In vitro effect of a fl avonoid-rich extract on LDL oxidation. Athelosclerosis 1996;123:83-91.
22. Pinder RM, Sandler M. Alcohol, wine and mental health: Focus on dementia and stroke. J Psychopharm 2004;18:449-56.
23. Moosmann B, Behl C. Antioxidants as treatment for neurodegenerative disorders. Expert Opin Investig Drugs 2002;11:1407-35.
24. Larson RA. The antioxidants of higher plants. Phytochemistry 1988;27:969-78.
25. Berger MM. Can oxidative damage be treated nutritionally? Clin Nutr 2005;24:172-83.
26. Floyd RA. Antioxidants, oxidative stress and degenerative neurological disorders. Proc Soc Exp Biol Med 1999;222:236-45.
27. Liu RH. Health benefi ts of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 2003;78:517S-20S.
28. Joseph JA. Bartus RT, Clody DE. Reversing the deleterious effects of aging on neuronal communication and behavior: Benefi cial properties of fruit polyphenolic compounds. Am J Clin Nutr 2005;81:313S-6S.
29. Ikeda K. Negishi H, Yamori Y. Antioxidant nutrients and hypoxia/ischemia brain injury in rodents. Toxicology 2003;189:55-61.
30. Guo S, Yan J, Yang T, Yang X, Bezard E, Zhao B. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway. Biol Psychiatry 2007;62:1353-62.
31. Zhang B, Safa R, Rusciano D, Osborne NN. Epigallocatechin gallate, an active ingredient from green tea, attenuates damaging infl uences to the retina caused by ischemia/reperfusion. Brain Res 2007;1159:40-53.
32. Ehrnhoefer DE, Duennwald M, Markovic P, Wacker JL, Engemann S. Green tea (α)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Hum Mol Genet 2006;15:2743-51.
33. Mandel SA, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, irondependent oxidative stress and PKC signaling pathway. Neurosignals 2005;14:46-60.
34. Sutherland BA, Rahman RM, Appleton I. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J Nutr Biochem 2005;17:291-306.
35. Youdim KA, Qaiser MZ, Begley DJ. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 2004;36:592-604 .
36. Youdim KA, Spencer JP, Schroeter H, Rice-Evans C. Dietary fl avonoids as potential neuroprotectants. Biol Chem 2002;383:503-19.
37. Pearson VE. Galantamine: A new Alzheimer drug with a past life. Ann Pharmacother 2001;35:1406-13.
38. Halliwell B. Oxidative stress and cancer: Have we moved forward? Biochem J 2007;401:1-11.
39. Ortiz JG, Nieves-Natal J, Chaves P. Effects of Valeriana offi cinalis extracts on [3H] fl unitrazepam binding, synaptosomal [3H] GABA uptake, and hippocampal [3H] GABA release. Neurochem Res 1999;24:1373-8.
40. Sakina MR, Dandiya PC. A psycho-neuropharmacological profi le of Centella asiatica extract. Fitoterapia 1990;61:291-6.
41. Crews C, Hough P, Godward J. Study of the main constituents of some authentic walnut oils. J Agric Food Chem 2005;53:4853-60.
42. McCann JC, Ames BN. Is docosahexaenoic acid, an n23 longchain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005;82:281-95.
43. Yehuda S, Rabinovitz S, Carasso RL. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 2002;23:843-53.
44. Zhao J, Kobori N, Aronowski J, Dash PK. Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett 2006;393:108-12.
45. Han JM, Lee YJ, Lee SY, Kim EM. Protective effect of sulforaphane against dopaminergic cell death. J Pharmacol Exp Ther 2007;321:249-56.
46. Schulz V, Hänsel R, Tyler V. Rational Phytotherapy: A Physician's Guide to Herbal Medicine. Berlin: Springer-Verlag; 1998 1-155.
47. Chatterjee SS, Bhattacharya SK, Wonneman M, Singer A, Muller WE. Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci 1998;63:499-510.
48. Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, et al. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 2007;1162:9-18.
49. Huang SS, Tsai MC, Chih CL, Hung LM, Tsai SK. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci 2001;69:1057-65.
50. Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 2005;37:349-50.
51. Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 2005;280:37377-82.
52. Oi YM, Imafuku C, Shishido Y, Kominato S, Nishimura K. Allyl-containing sulfi des in garlic increase uncoupling protein content in brown adipose tissue, and noradrenaline and adrenaline secretion in rats. J Nutr 1999;129:336-42.
53. Winkler J, Suhr ST, Gage FH, Thal LJ, Fischer LJ. Essential role of neocorticat acetylcholine in spatial memory. Nature 1995;375:484-7.
54. Curtis DR, Duggan AW, Felix D, Johnston GA. Bicuculline and central GABA receptors. Nature 1970;228:676-7.
55. Jarboe CH, Porter LA, Buckler RT. Structural aspects of picrotoxinin action. J Med Chem 1968;2:729-31.
56. Johnston GA. GABAA receptor channel pharmacology. Curr Pharm Design 2005;11:1867-85.
57. Zanoli P, Avallone R, Baraldi M. Sedative and hypothermic effects induced by b-asarone, a main component of Acorus Calamus. Phytother Res 1998;12:114-6.
58. Gupta P, Siripurapu KB, Ahmad A, Palit G, Arrora A, Maurya R. Antistress constituents of Evolvulus alsinoides, an ayurvedic crude drug. Chem Pharma Bull 2007;55:771-6.
59. Dhingra D, Parle M, Kulkarni SK. Memory enhancing activity of Glycyrrhiza Glabra in mice. J Ethnopharmacol 2004;91:361-5.
60. Rui DS, Prediger M, Fernandes S, Daniel RS. Effects of acute administration of hydroalcoholic extract of mate tea leaves (Ilex Paraguariensis) in animal models of learning and memory. J Ethanopharmacol 2008;120:465-73.
61. Lee H, Kim YO, Kim H. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting infl ammatory activation of microglia. FASEB J 2003;17:1943-4.
62. Topic B, Tani E, Tsiakitzis K, Kourounakis PN, Dere E, Hasenohrl RU, et al. Enhanced maze performance and reduced oxidative stress by combined extracts of Zingiber Offi cinals and Ginkgo Biloba in the aged rat. Neurobiol Ageing 2002;23:135-43.
63. Lu YJ, Zhou J, Zhang SM, Zhang HY, Zheng XX. Inhibitory effects of jujuboside A on EEG and hippocampal glutamate in hyperactive rat. J Zhejiang Univ Sci B 2005;6:265-71.
64. Jussofi e A, Schmiz A, Hiemke C. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA bindingsite in different regions of rat brain. Psychopharmacology (Berl) 1994;116:469-74.
65. Misra R. Modern drug development from traditional medicinal plants using radioligand rexceptor-binding assays. Med Res Rev 1998;18:383-402.
66. Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V. Systemic administration of defi ned extracts from Withania somnifera (Indian Ginseng) and shilajit differentially affects cholinergic but not glutamatergic and gabaergic markers in rat brain. Neurochem Int 1997;30:181-90.